Buy & Sell iShares 7-10 Year Treasury Bond ETF (IEF) – iShares 7-10 Year Treasury Bond ETF Price Today
Key Stats
- -Market Cap
- -Sector
- -3.76%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 91 daysTypical Hold Time
Over the past 52 weeks, iShares 7-10 Year Treasury Bond ETF has traded between a low of $93.11 and a high of $97.99, highlighting its annual price range. Over the past three months, iShares 7-10 Year Treasury Bond ETF has recorded a drawdown of -3.76%, reflecting recent price volatility. On average, investors hold iShares 7-10 Year Treasury Bond ETF for approximately 91 days, indicating typical investor behavior on the platform.
About iShares 7-10 Year Treasury Bond ETF
The underlying index measures the performance of public obligations of the US Treasury that have a remaining maturity of greater than or equal to seven years and less than ten years. The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in US Treasury securities that the advisor believes will help the fund track the underlying index.
Most Recent News
American Airlines suspends six domestic routes this summer amid rising fuel costs linked to Iran conflict
American Airlines will temporarily suspend six domestic routes from August to September due to rising jet fuel costs driven by the Iran conflict. The affected routes include flights from Los Angeles to Cleveland, Columbus, Pittsburgh, and Washington ...

OpenAI plans major upgrade to boost ChatGPT amid IPO and competition with Anthropic.
OpenAI is preparing its biggest upgrade yet, transforming ChatGPT into a superapp with multiple tools like coding and AI agents to better compete with Anthropic. This move aims to attract more corporate clients and increase revenue as OpenAI readies ...

Repatha cuts first major cardiovascular event risk by 29% in high-risk diabetes patients, new trial data show
New Phase 3 VESALIUS-CV trial data reveal that Repatha (evolocumab), added to statins, reduces the risk of first major cardiovascular events by 29% in patients with high-risk diabetes and elevated LDL cholesterol. The study involved 6,002 patients wi...
